“Elevated levels of circulating soluble ST2 at discharge predict late adverse ventricular remodeling in patients with ST-segment elevation myocardial infarction” (2018) Biomedical Research and Therapy, 5(12), pp. 2863–2875. doi:10.15419/bmrat.v5i12.505.